natgillin/translations-raw huggingface dataset:
Somatropin Biopartners 2 mg powder and solvent for prolonged-release suspension for injection
Somatropin Biopartners 2 mg prašek in vehikel za suspenzijo za injiciranje s podaljšanim sproščanjem
Somatropin Biopartners 2 mg powder for prolonged-release suspension for injection somatropin
Somatropin Biopartners 2 mg prašek za suspenzijo za injiciranje s podaljšanim sproščanjem somatropin
Somatropin Biopartners 2 mg: 2 mg (6 IU) somatropin as powder in a glass vial closed with a rubber stopper (butyl) and a yellow flip-off cap (aluminium and plastic) and 1.5 mL solvent (medium chain triglycerides) in a glass vial with a rubber stopper (butyl).
Somatropin Biopartners 2 mg: 2 mg (6 i.e.) somatropina v obliki praška v stekleni viali, zaprti z gumijastim zamaškom (butil) in rumeno prekrivno zaporko (aluminij in plastika) in 1,5 ml vehikla (srednjeverižni trigliceridi) v stekleni viali z gumijastim zamaškom (butil).
Somatropin Biopartners 2 mg: One vial of powder delivers 2 mg somatropin, corresponding to 6 IU.
Somatropin Biopartners 2 mg: Ena viala s praškom dostavi 2 mg somatropina, kar ustreza 6 i.e..
Somatropin Biopartners 20 mg powder and solvent for prolonged-release suspension for injection somatropin
Somatropin Biopartners 20 mg prašek in vehikel za suspenzijo za injiciranje s podaljšanim sproščanjem
Somatropin Biopartners 20 mg powder for prolonged-release suspension for injection somatropin
Somatropin Biopartners 20 mg prašek za suspenzijo za injiciranje s podaljšanim sproščanjem somatropin
Somatropin Biopartners 20 mg: 20 mg (60 IU) somatropin as powder in a glass vial closed with a rubber stopper (butyl) and a green flip-off cap (aluminium and plastic) and 1.5 mL solvent (medium chain triglycerides) in glass vial with a rubber stopper (butyl).
Somatropin Biopartners 20 mg: 20 mg (60 i.e.) somatropina v obliki praška v stekleni viali, zaprti z gumijastim zamaškom (butil) in zeleno prekrivno zaporko (aluminij in plastika) in 1,5 ml vehikla (srednjeverižni trigliceridi) v stekleni viali z gumijastim zamaškom (butil).
Somatropin Biopartners 20 mg: One vial of powder delivers 20 mg somatropin, corresponding to 60 IU.
Somatropin Biopartners 10 mg: Ena viala s praškom dostavi 20 mg somatropina, kar ustreza 60 i.e..
Somatropin Biopartners 4 mg powder and solvent for prolonged-release suspension for injection
Somatropin Biopartners 4 mg prašek in vehikel za suspenzijo za injiciranje s podaljšanim sproščanjem
Somatropin Biopartners 4 mg powder for prolonged-release suspension for injection somatropin
Somatropin Biopartners 4 mg prašek za suspenzijo za injiciranje s podaljšanim sproščanjem somatropin
Somatropin Biopartners 4 mg: One vial of powder delivers 4 mg somatropin, corresponding to 12 IU.
Somatropin Biopartners 4 mg: Ena viala s praškom dostavi 4 mg somatropina, kar ustreza 12 i.e..
Somatropin Biopartners 7 mg powder and solvent for prolonged-release suspension for injection
Somatropin Biopartners 7 mg prašek in vehikel za suspenzijo za injiciranje s podaljšanim sproščanjem
Somatropin Biopartners 7 mg powder for prolonged-release suspension for injection somatropin
Somatropin Biopartners 7 mg prašek za suspenzijo za injiciranje s podaljšanim sproščanjem somatropin
Somatropin Biopartners 7 mg: 7 mg (21 IU) somatropin as powder in a glass vial closed with a rubber stopper (butyl) and a light-blue flip-off cap (aluminium and plastic) and 1.5 mL solvent (medium chain triglycerides) in glass vial with a rubber stopper (butyl).
Somatropin Biopartners 7 mg: 7 mg (21 i.e.) somatropina v obliki praška v stekleni viali, zaprti z gumijastim zamaškom (butil) in svetlomodro prekrivno zaporko (aluminij in plastika) in 1,5 ml vehikla (srednjeverižni trigliceridi) v stekleni viali z gumijastim zamaškom (butil).
Somatropin Biopartners 7 mg: One vial of powder delivers 7 mg somatropin, corresponding to 21 IU.
Somatropin Biopartners 7 mg: Ena viala s praškom dostavi 7 mg somatropina, kar ustreza 21 i.e..
Somatropin Biopartners must not be used in patients with an active tumour or an acute life- threatening illness.
Zdravilo Somatropin Biopartners se ne sme uporabljati pri bolnikih z aktivnim tumorjem ali z akutno življenjsko nevarno boleznijo.
Somatropin Biopartners replaces the natural hormone.
Zdravilo Somatropin Biopartners nadomesti naravni hormon.
Somatropin Biopartners should not be used in infants below the age of 2 years.
Zdravila Somatropin Biopartners ne uporabljajte pri dojenčkih, starih manj kot 2 leti.
Somatropin dose (mg)
Odmerek somatropina (mg)
Somatropin has no known effect on the ability to drive or to use machines.
Somatropin nima znanega vpliva na sposobnost vožnje in upravljanja s stroji.
Somatropin is known to be associated with inhibition of the reproduction in male and female rats at doses of 3 IU/kg/day (1 mg/kg/day) or more, with reduced copulation and conception rates, lengthened or absent oestrous cycles, and at
Znano je, da somatropin pri odmerkih 3 i.e./kg/dan (1 mg/kg/dan) ali večjih zavira procese razmnoževanja pri samcih in samicah podgan, pri čemer se zmanjša delež parjenj in koncepcij, estrusni cikel pa se pri odmerku
Somatropin may interfere with the body’s use of insulin.
Somatropin lahko vpliva na izrabo insulina v telesu.
Somatropin may interfere with the body’s use of insulin.
Somatropin lahko vpliva na presnovo insulina v telesu.
Somatropin must not be used for growth promotion in children with closed epiphyses.
Somatropina se ne sme uporabljati za spodbujanje rasti pri otrocih z zaprtimi epifizami.
Somatropin must not be used when there is any evidence of tumour activity.
Somatropina se ne sme uporabljati, če obstajajo znaki dejavnega tumorja.
Somatropin stimulates the synthesis of chondroitin sulphate and collagen as well as the urinary excretion of hydroxyproline.
Somatropin stimulira sintezo hondroitin sulfata in kolagena ter izločanje hidroksiprolina v urinu.
Somatropin treatment must not be started in patients with acute critical illness due to complications following open heart or abdominal surgery, multiple accidental trauma, or to patients having acute respiratory failure or similar conditions.
S somatropinom se ne sme zdraviti bolnikov z akutno kritično boleznijo, nastalo zaradi zapletov po operaciji na odprtem srcu ali v trebuhu, bolnikov z večkratnimi nezgodnimi poškodbami ter bolnikov z akutno odpovedjo dihanja ali podobnimi stanji.
Somatropin – a growth hormone.
Somatropin – rastni hormon.
SOMAVERT 10 mg and 15 mg
SOMAVERT 10 mg in 15 mg
SOMAVERT 10 mg powder and solvent for solution for injection SOMAVERT 15 mg powder and solvent for solution for injection SOMAVERT 20 mg powder and solvent for solution for injection SOMAVERT 25 mg powder and solvent for solution for injection SOMAVERT 30 mg powder and solvent for solution for injection Pegvisomant
SOMAVERT 10 mg prašek in vehikel za raztopino za injiciranje SOMAVERT 15 mg prašek in vehikel za raztopino za injiciranje SOMAVERT 20 mg prašek in vehikel za raztopino za injiciranje SOMAVERT 25 mg prašek in vehikel za raztopino za injiciranje SOMAVERT 30 mg prašek in vehikel za raztopino za injiciranje pegvisomant
SOMAVERT 10 mg: One vial of powder contains 10 mg pegvisomant.
SOMAVERT 10 mg: Ena viala s praškom vsebuje 10 mg pegvisomanta.
SOMAVERT 15 mg: One vial of powder contains 15 mg pegvisomant.
SOMAVERT 15 mg: Ena viala s praškom vsebuje 15 mg pegvisomanta.
SOMAVERT 20 mg, 25 mg and 30 mg
SOMAVERT 20 mg, 25 mg in 30 mg
SOMAVERT 20 mg: One vial of powder contains 20 mg pegvisomant.
SOMAVERT 20 mg: Ena viala s praškom vsebuje 20 mg pegvisomanta.
SOMAVERT 25 mg: One vial of powder contains 25 mg pegvisomant.
SOMAVERT 25 mg: Ena viala s praškom vsebuje 25 mg pegvisomanta.
SOMAVERT 30 mg: One vial of powder contains 30 mg pegvisomant.
SOMAVERT 30 mg: Ena viala s praškom vsebuje 30 mg pegvisomanta.
SOMAVERT contains sodium
Zdravilo SOMAVERT vsebuje natrij
Somavert is a powder and solvent that are mixed together to make up a solution for injection.
Zdravilo Somavert sestavljata prašek in vehikel, ki se zmešata v raztopino za injiciranje.
Somavert is given by injection under the skin.
Zdravilo se injicira pod kožo.
SOMAVERT is presented as a powder and a solvent for injection (either 10 mg, 15 mg, 20 mg, 25 mg or 30 mg pegvisomant in a vial and 1 ml of solvent in a pre-filled syringe).
Zdravilo SOMAVERT je na voljo kot prašek in vehikel za raztopino za injiciranje (10 mg, 15 mg, 20 mg, 25 mg oziroma 30 mg pegvisomanta v viali in 1 ml vehikla v napolnjeni injekcijski brizgi).
Somavert is used in patients who did not respond well to surgery and/or radiation therapy, and to treatment with somatostatin analogues (another type of medicine used in acromegaly).
Zdravilo se uporablja pri bolnikih, ki se niso dobro odzvali na kirurški poseg in/ali obsevanje ali zdravljenje z analogi somatostatina (druge vrste zdravila, ki se uporablja za zdravljenje akromegalije).
Somavert is used to treat adults with acromegaly (a rare hormonal disorder that usually occurs in middle-aged adults, which is caused by the pituitary gland producing excess growth hormone).
Zdravilo Somavert se uporablja za zdravljenje bolnikov z akromegalijo (redko hormonsko motnjo, ki se navadno pojavlja pri odraslih srednjih let, povzroči pa jo hipofiza, ki izloča preveč rastnega hormona).
Somavert powder in vial with solvent in a pre-filled syringe pegvisomant for injection
Somavert prašek v viali z vehiklom v napolnjeni injekcijski brizgi pegvisomant za injiciranje
Some additional data have been obtained from a number of patients in a compassionate use programme.
Do dodatnih rezultatov so prišli pri številnih bolnikih, vključenih v program sočutne uporabe.
Some adverse reactions (e.g. fatigue, asthenia, visual disturbances, dizziness) may impair patient’s ability to concentrate and react.
Nekateri neželeni učinki (npr. utrujenost, astenija, motnje vida, omotica) lahko vplivajo na bolnikovo sposobnost koncentracije in reagiranja.
Some adverse reactions were also identified during post marketing surveillance.
Nekaj neželenih učinkov so opazili tudi med nadzorom v obdobju trženja zdravila.
Some animals may also not show titres > 0.5 IU/ml after single primary vaccination.
Nekatere živali po osnovnem cepljenju z enim odmerkom nimajo titra protiteles večjega od 0.5 IU/ml.
Some animals may also not show titres > 0.5 IU/ml after single primary vaccination.
Nekatere živali po prvem cepljenju enim odmerkom nimajo titra protiteles večjega od 0.5 IU/ml.
Some anti-epileptic drugs known as enzyme inducers (carbamazepine, phenytoin, oxcarbazepine) have been shown to increase perampanel clearance and consequently to decrease plasma concentrations of perampanel.
Nekatera antiepileptična zdravila, znana kot induktorji encima (karbamazepin, fenitoin, okskarbazepin) povečala očistek perampanela in posledično zmanjšajo koncentracijo perampanela v plazmi.
Some antibiotics, such as ciprofloxacin and tetracycline.
nekateri antibiotiki, kot sta ciprofloksacin in tetraciklin,
Some antidepressant medicines like vortioxetine may reduce the quality of sperm in animals.
Nekateri antidepresivi, podobni vortioksetinu, zmanjšajo kakovost sperme pri živalih.
Some are very common (may affect more than 1 in 10 people), some are common (may affect up to 1 in 10 people):
Nekateri med njimi so zelo pogosti (do njih pride pri več kot 1 od 10 bolnikov), nekateri pa so pogosti (do njih pride pri največ 1 od 10 bolnikov):
Some bleeding events (MBEs/CRBEs; any bleeding) were significantly lower at a nominal alpha level of 5% in patients receiving dabigatran etexilate as compared with those receiving warfarin.
Nekatere krvavitve (velike krvavitve/klinično pomembne krvavitve; vse krvavitve) so bile na 5-odstotni nominalni ravni alfa značilno redkejše pri bolnikih, ki so prejemali dabigatran eteksilat, kot pri zdravljenih z varfarinom.
Some cases have occurred in patients with central nervous system (CNS) herpes infections (e.g. herpes meningitis and encephalitis).
Nekateri primeri so se pojavili pri bolnikih z okužbami osrednjega živčnega sistema s herpesom (npr. herpetični meningitis in encefalitis).
Some cases may require longer treatment.
Nekateri primeri zahtevajo daljše zdravljenje.
Some cases of severe vomiting were associated with
v nekaterih primerih je bilo hudo bruhanje povezano z
Some cases of severe vomiting were associated with oesophageal rupture (see section 4.4).
Nekateri primeri hudega bruhanja so bili povezani z rupturo ezofagusa (glejte poglavje 4.4).
Some cases of severe vomiting were associated with oesophageal rupture (see section 4.4).
v nekaterih primerih je bilo hudo bruhanje povezano z rupturo požiralnika (glejte poglavje 4.4)
Some cases of splenic rupture were fatal (see section 4.4).
Nekateri primeri raztrganja vranice so bili usodni (glejte poglavje 4.4.).
Some cases of splenic rupture were fatal.
Nekateri primeri rupture vranice so bili smrtni.
Some cases of splenic rupture were fatal.
Za nekatere bolnike je bilo raztrganje vranice usodno.
Some children and teenage patients who have received TNF-blockers such as Flixabi have developed cancers, including unusual types, which sometimes resulted in death.
Pri nekaterih otrocih in najstnikih, ki so prejemali zaviralce TNF, kot je zdravilo Flixabi, se je razvil rak, vključno z neobičajnimi oblikami, ki se je včasih končal s smrtnim izidom.
Some children and teenage patients who have received TNF-blockers such as Inflectra have developed cancers, including unusual types, which sometimes resulted in death.
Pri nekaterih pediatričnih bolnikih in bolnikih mladostnikih, ki so prejemali zaviralce TNF, kot je zdravilo Inflectra, se je razvil rak, vključno z zelo neobičajnimi oblikami, ki se včasih končajo s smrtnim izidom.
Some children and teenage patients who have received TNF-blockers such as Remicade have developed cancers, including unusual types, which sometimes resulted in death.
Pri nekaterih otrocih in najstnikih, ki so prejemali zaviralce TNF, kot je zdravilo Remicade, se je razvil rak, vključno z zelo neobičajnimi oblikami, ki se včasih končajo s smrtnim izidom.
Some children and teenage patients who have received TNF-blockers such as Remsima have developed cancers, including unusual types, which sometimes resulted in death.
Pri nekaterih otrocih in najstnikih, ki so prejemali zaviralce TNF, kot je zdravilo Remsima, se je razvil rak, vključno z zelo neobičajnimi oblikami, ki se včasih končajo s smrtnim izidom.
Some children did not reach their projected height within 1-5 years after completing treatment.
Nekateri otroci tudi niso dosegli pričakovane telesne višine v obdobju 1 do 5 let po zaključku zdravljenja.
Some corticosteroids may cause sodium and water retention and hypokalaemia in long term use.
Nekateri kortikosteroidi lahko ob dolgotrajni uporabi povzročijo zastajanje natrija in vode ter hipokaliemijo.
Some cross-protection was observed against related H5N1 virus variants in clinical trials (see section 5.1).
V kliničnih preskušanjih so opazili določeno stopnjo navzkriţne zaščite proti različicam virusa H5N1 (glejte poglavje 5.1).
Some cross-protection was observed against related H5N1 virus variants in clinical trials (see section 5.1).
V kliničnih preskušanjih so opazili določeno stopnjo navzkrižne zaščite proti sorodnim različicam virusa H5N1 in (glejte poglavje 5.1).
Some dogs (less than 10%) experienced repeated vomiting (i.e. more than once every 20 days on average).
Pri nekaterih psih (manj kot 10 %) se bruhanje ponavlja (to je v povprečju več kot enkrat na vsakih 20 dni).
Some dogs and cats may also vomit at the time of recovery.
Nekateri psi in mačke lahko bruhajo tudi po prenehanju delovanja.
Some dogs do not need daily treatment; treatment every other day may be tried once the effective daily dose has been established.
Nekatere psice zdravila ne potrebujejo vsak dan; ko določimo učinkovit dnevni odmerek, lahko poskusimo zdravilo dajati vsak drugi dan.
Some dogs do not need daily treatment; treatment every other day may be tried, once the effective daily dose has been established.
Nekatere psice zdravila ne potrebujejo vsak dan; ko določimo učinkovit dnevni odmerek, lahko zdravilo poskusimo dajati vsak drugi dan.
Some dogs will be free of seizures, in other dogs a reduction of the number of seizures will be observed, whilst others will be non-responders.
Nekateri psi epileptičnih napadov ne bodo imeli, pri drugih jih bo manj, nekateri pa se ne bodo odzvali.
Some effect on progression of disability could be seen, but only in the patients who had relapses in the two years before the start of the study.
Nekaj učinkov na napredovanje nesposobnosti je mogoče opaziti le pri tistih bolnikih, ki so imeli zagone dve leti pred začetkom študije.
Some everyday medicines interact with Revolade – including prescription and non-prescription medicines and minerals.
Nekatera vsakdanja zdravila vplivajo na delovanje zdravila Revolade – vključno z zdravili na recept in zdravili, ki jih lahko dobite brez recepta ter minerali.
Some examples include, but are not limited to, etravirine, efavirenz, nevirapine, boceprevir, fluticasone, and bosentan (see Table 2).
Nekateri primeri vključujejo etravirin, efavirenz, nevirapin, boceprevir, flutikazon in bosentan, vendar pa niso omejeni nanje (glejte preglednico 2).
Some examples include, but are not limited to, itraconazole, ketoconazole, and voriconazole (see Table 2).
Nekateri primeri vključujejo itrakonazol, ketokonazol in vorikonazol, vendar pa niso omejeni nanje (glejte preglednico 2).
Some examples include:
Med njimi so:
Some examples of age-appropriate soft foods or liquids include puréed fruits or vegetables, yogurt, applesauce, water, milk, or juice.
Primeri za starost primerne mehke hrane ali tekočine so sadni pireji ali zelenjavni jogurti, jabolčni sok, voda, mleko ali sok.
Some eye-drops contain a preservative called ‘benzalkonium chloride’.
Nekatere kapljice za oko vsebujejo konzervans, imenovan benzalkonijev klorid.
Some factors that may raise urine pH (see section 5.2 'Elimination') may necessitate careful monitoring of the patient.
Kadar so prisotni nekateri dejavniki, ki lahko zvišajo pH urina (glejte poglavje 5.2 Izločanje), je potreben skrben nadzor bolnika.
Some factors that may raise urine pH (see section 5.2 ‘Elimination’) may necessitate careful monitoring of the patient.
Kadar so prisotni nekateri dejavniki, ki lahko zvišajo pH urina (glejte poglavje 5.2 ‘Izločanje’), je potreben skrben nadzor bolnika.
some fatal cases
primeri
some fatal cases
primeri (glejte
some fatal cases (see section 4.4) 11
primeri (glejte poglavje 4.4)11
Some fatal cases of hepatic failure and of hepatic necrosis have been reported.
Poročali so o nekaj primerih odpovedi jeter in nekroze jeter s smrtnim izidom.
Some fatal cases or cases requiring liver transplantation have been reported.
Poročali so o primerih, ki so se končali s smrtjo ali primerih, ki so zahtevali presaditev jeter.
Some fatal cases or cases requiring liver transplantation have been reported.Cholelithiasis
Poročali so o nekaterih smrtnih primerih ali primerih, kjer je bila potrebna presaditev jeter.
Some fatalities have occurred, primarily with mixed overdoses, but also with duloxetine alone at a dose of approximately 1,000 mg.
Bilo je nekaj smrtnih primerov, zlasti ob mešanih prevelikih odmerjanjih, vendar tudi ob duloksetinu samemu v odmerku približno 1000 mg.
Some fatalities have occurred, primarily with mixed overdoses, but also with duloxetine alone at a dose of approximately 1000 mg.
Bilo je nekaj smrtnih primerov, zlasti ob mešanih prevelikih odmerjanjih, vendar tudi ob duloksetinu samemu v odmerku približno 1000 mg.
Some improvements have also been shown in patients with class II PAH. ‘Class II’ involves slight limitation of physical activity.
Nekatera izboljšanja so opazili tudi pri bolnikih s PAH razreda II. ‘Razred II’ pomeni blago omejitev fizične aktivnosti.
Some improvements have also been shown in patients with pulmonary arterial hypertension WHO functional class II (see section 5.1).
Določena izboljšanja so se pokazala tudi pri bolnikih s pljučno arterijsko hipertenzijo II. funkcijskega razreda SZO (glejte poglavje 5.1).
Some infections were severe or fatal.
Nekatere okužbe so bile hude ali smrtne.
Some insulins are cloudy while others are clear, be sure to refer to your insulin package leaflet for the appearance of your specific insulin.
Nekateri insulini so motni, medtem ko so drugi bistri, prepričajte se, da sledite Navodilu za uporabo za insulin glede izgleda vašega določenega insulina.
Some late- onset neurological disorders have been reported (hypertonia, convulsion, abnormal behaviour).
Opisane so nekatere nevrološke motnje s poznim nastankom (hipertonija, konvulzije, nenormalno vedenje).
Some late-onset neurological disorders have been reported (hypertonia, convulsion, abnormal behaviour).
Opisane so nekatere nevrološke motnje s poznim nastankom (hipertonija, konvulzije, nenormalno vedenje).
Some late-onset neurological disorders have been reported (hypertonia, convulsion, abnormal behaviour).
Poročali so o nekaterih primerih nevroloških motenj, ki nastopijo pozneje (hipertonija, konvulzije, nenormalno vedenje).
Some lung problems may get worse during treatment with IRESSA. if you have ever had problems with your liver.
Nekatere težave s pljuči se lahko med zdravljenjem z zdravilom IRESSA poslabšajo. če ste kdaj imeli težave z jetri.
Some medic may come out – this is normal.
Nekaj zdravila lahko izteče ven – to je normalno.
Some medicines affect your blood sugar level - this may mean your insulin dose has to change.
Nekatera zdravila vplivajo na koncentracijo krvnega sladkorja, kar pomeni, da bo morda potrebna sprememba vašega odmerka insulina.
Some medicines affect your blood sugar level – this may mean your insulin dose has to change.
Nekatera zdravila vplivajo na koncentracijo krvnega sladkorja, kar pomeni, da bo morda potrebna sprememba vašega odmerka insulina.
Some medicines affect your blood sugar level – this may mean your Xultophy dose has to change.
Nekatera zdravila lahko vplivajo na koncentracijo krvnega sladkorja, zaradi tega pa bo odmerek zdravila Xultophy morda treba spremeniti.
Some medicines can affect how Kalydeco works, or make it more likely that you will have side effects.
Nekatera zdravila vplivajo na delovanje zdravila Kalydeco ali povzročijo, da boste z večjo verjetnostjo imeli neželene učinke.
Some medicines can affect how Kalydeco works, or make it more likely that your child will have side effects.
Nekatera zdravila vplivajo na delovanje zdravila Kalydeco ali povzročijo, da bo imel vaš otrok z večjo verjetnostjo neželene učinke.
Some medicines can increase the levels of the active substances of IOA in the blood.
Nekatera zdravila lahko povečajo koncentracijo zdravilnih učinkovin zdravila IOA v krvi.
Some medicines can increase the levels of the active substances of Zoely in the blood.
Nekatera zdravila lahko povečajo koncentracijo zdravilnih učinkovin zdravila Zoely v krvi.
Some medicines can interfere with the breakdown or metabolism of Torisel and therefore dose adjustment of Torisel may be required.
Nekatera zdravila lahko ovirajo razgradnjo ali presnovo zdravila Torisel in zato utegne biti potrebna prilagoditev odmerka zdravila Torisel.
Some medicines can make it more likely that you will have side effects, or make side effects worse
Nekatera zdravila povečajo verjetnost neželenih učinkov ali lahko neželene učinke poslabšajo.
Some medicines can make it more likely that you’ll have side effects, or make side effects worse.
Nekatera zdravila lahko povečajo verjetnost, da boste imeli neželene učinke, ali pa da bodo neželeni učinki hujši.
Some medicines cause changes in the blood sugar level (decrease, increase or both depending on the situation).
Nekatera zdravila lahko spremenijo koncentracijo krvnega sladkorja (jo znižajo, zvišajo ali oboje, odvisno od okoliščin).
Some medicines cause changes in the blood sugar level (decrease, increase or both depending on the situation).
Nekatera zdravila povzročijo spremembe koncentracije krvnega sladkorja (znižanje, zvišanje ali oboje,, odvisno od okoliščin).
Some medicines cause changes in the blood sugar level (decrease, increase or both depending on the situation).
Nekatera zdravila povzročijo spremembe koncentracije krvnega sladkorja (znižanje, zvišanje ali oboje,odvisno od okoliščin).